Modafinil has been reported to dramatically reduce fatigue and improve physical function in one published case of chronic back and neck pain, even though the patient’s pain level did not change. No randomized controlled trials have tested modafinil specifically for back pain-related fatigue, and the drug is not approved for that purpose. The available evidence…

Modafinil reduces excessive daytime sleepiness. It acts on brain systems that regulate wakefulness rather than on the body’s energy production systems. In people with disorders marked by pathological sleepiness, that increase in alertness can feel like more energy, but the drug’s primary effect is promoting wakefulness. Key Takeaways Wakefulness Is Not the Same as Energy…

Modafinil does not increase IQ in healthy people. In controlled testing of student volunteers, it changed performance on a small number of cognitive tasks, and those effects depended on baseline IQ. Broader cognitive benefits in healthy individuals remain uncertain. Key Takeaways Does Modafinil Raise IQ? IQ reflects general intellectual ability. In controlled testing, modafinil did…

Most people who take modafinil daily do not need to cycle it to prevent tolerance. Long-term clinical observation shows that doses tend to stabilize after initial titration and do not drift upward over time. Approved prescribing guidance does not recommend scheduled drug holidays, and the drug’s pharmacology differs enough from classical stimulants that the cycling…

Yes, you can take modafinil with an energy drink, but doing so increases total stimulant exposure and makes side effects more likely. Modafinil is a wakefulness-promoting medication approved for narcolepsy, shift work disorder, and obstructive sleep apnea–related sleepiness. Energy drinks typically contain caffeine, another stimulant. The combination is not listed as contraindicated, but overlapping stimulant…

Modafinil can improve depressive symptoms in some patients with bipolar depression when added to a mood stabilizer, but it is not approved as an antidepressant. In a six week placebo controlled trial of 85 patients, adjunctive modafinil produced higher response and remission rates than placebo. The evidence comes from short term data, and psychiatric safety…

Current prescribing references do not identify a known drug–drug interaction between modafinil and gabapentin. However, the combination has not been studied in controlled clinical trials, so conclusions about safety rest on the absence of reported interaction concerns rather than direct evidence. For most adults without significant renal, psychiatric, or substance-use risk factors, using both medications…

Yes. Nerve pain appears to be a rare but real side effect of modafinil, documented in a published clinical case and reflected in specific patient accounts. It is not a common reaction and does not affect most users, but when it occurs, it can be severe and warrants prompt attention. Most people take modafinil without…